On February 24, 2010
Look Behind Icahn’s Battle for Control of Genzyme — It’s the ImClone War, Part Deux
Don’t be distracted in Carl Icahn’s fight for control of Genzyme (GENZ). This is not, as the billionaire activist shareholder has told investors, an “attempt to fix what is broken” in Genzyme’s management. Rather, it’s ImClone Part 2.
…
0 Comments